BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

196 related articles for article (PubMed ID: 7359684)

  • 1. Sulindac-induced Stevens-Johnson toxic epidermal necrolysis syndrome.
    Levitt L; Pearson RW
    JAMA; 1980 Mar; 243(12):1262-3. PubMed ID: 7359684
    [No Abstract]   [Full Text] [Related]  

  • 2. Stevens-Johnson syndrome due to sulindac: a case report and review of the literature.
    Maguire FW
    Del Med J; 1981 Apr; 53(4):193-7. PubMed ID: 7227578
    [No Abstract]   [Full Text] [Related]  

  • 3. Sulindac-induced Stevens-Johnson syndrome: report of 3 cases.
    Husain Z; Runge LA; Jabbs JM; Hyla JA
    J Rheumatol; 1981; 8(1):176-9. PubMed ID: 7218253
    [No Abstract]   [Full Text] [Related]  

  • 4. Hepatitis, toxic epidermal necrolysis and pancreatitis in association with sulindac therapy.
    Klein SM; Khan MA
    J Rheumatol; 1983 Jun; 10(3):512-3. PubMed ID: 6224935
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A fatal case of sulindac-induced Lyell syndrome (toxic epidermal necrolysis).
    Ikeda N; Umetsu K; Suzuki T
    Z Rechtsmed; 1987; 98(2):141-6. PubMed ID: 3604469
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Development of Stevens-Johnson syndrome following sulindac administration in a patient with mixed connective tissue disease].
    Awaya N; Fujii T; Akizuki M
    Ryumachi; 1993 Oct; 33(5):432-6. PubMed ID: 8256166
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Serious adverse reactions associated with sulindac.
    Park GD; Spector R; Headstream T; Goldberg M
    Arch Intern Med; 1982 Jul; 142(7):1292-4. PubMed ID: 6212034
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Medications as risk factors of Stevens-Johnson syndrome and toxic epidermal necrolysis in children: a pooled analysis.
    Levi N; Bastuji-Garin S; Mockenhaupt M; Roujeau JC; Flahault A; Kelly JP; Martin E; Kaufman DW; Maison P
    Pediatrics; 2009 Feb; 123(2):e297-304. PubMed ID: 19153164
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Lyell's syndrome and sulindac apropos of a case].
    Chevrant Breton J; Pibouin M; Allain H; Beneton C; Milon J; Lancien G
    Therapie; 1985; 40(1):67. PubMed ID: 4002185
    [No Abstract]   [Full Text] [Related]  

  • 10. [Severe skin reactions. Toxic epidermal necrolysis, Stevens-Johnson syndrome, erythema exsudativum multiforme majus and generalized bullous fixed drug exanthema].
    Rzany B; Mockenhaupt M; Baur S; Stocker U; Schöpf E
    Hautarzt; 1993 Aug; 44(8):549-54; quiz 554-6. PubMed ID: 8376113
    [No Abstract]   [Full Text] [Related]  

  • 11. [Stevens-Johnson syndrome and toxic epidermal necrolysis following intake of sulfonamides].
    Aberer W; Stingl G; Wolff K
    Hautarzt; 1982 Sep; 33(9):484-90. PubMed ID: 7174320
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Toxic epidermal necrolysis in Stevens--Johnson syndrome.
    Assaad D; From L; Ricciatti D; Shapero H
    Can Med Assoc J; 1978 Jan; 118(2):154-6. PubMed ID: 757383
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Toxic epidermal necrolysis. Improved prognosis with biological dressings].
    Rodt SA; Gjengstø H; Pitkanen J
    Tidsskr Nor Laegeforen; 1986 Dec; 106(34-36):2982-3. PubMed ID: 3810621
    [No Abstract]   [Full Text] [Related]  

  • 14. Stevens-Johnson syndrome and toxic epidermal necrolysis: a review of the literature.
    Letko E; Papaliodis DN; Papaliodis GN; Daoud YJ; Ahmed AR; Foster CS
    Ann Allergy Asthma Immunol; 2005 Apr; 94(4):419-36; quiz 436-8, 456. PubMed ID: 15875523
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sulindac-induced toxic epidermal necrolysis.
    Small RE; Garnett WR
    Clin Pharm; 1988 Oct; 7(10):766-71. PubMed ID: 3233897
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Stevens-Johnson syndrome/toxic epidermal necrolysis].
    Watanabe H; Iijima M
    Nihon Rinsho; 2007 Oct; 65 Suppl 8():336-40. PubMed ID: 18072345
    [No Abstract]   [Full Text] [Related]  

  • 17. Stevens-Johnson syndrome and toxic epidermal necrolysis.
    Eginli A; Shah K; Watkins C; Krishnaswamy G
    Ann Allergy Asthma Immunol; 2017 Feb; 118(2):143-147. PubMed ID: 28153080
    [No Abstract]   [Full Text] [Related]  

  • 18. Nitric oxide synthase in toxic epidermal necrolysis and Stevens-Johnson syndrome.
    Lerner LH; Qureshi AA; Reddy BV; Lerner EA
    J Invest Dermatol; 2000 Jan; 114(1):196-9. PubMed ID: 10620138
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Stevens-Johnson/toxic epidermal necrolysis overlap syndrome following lenalidomide treatment for multiple myeloma relapse after allogeneic transplantation.
    Wäsch R; Jakob T; Technau K; Finke J; Engelhardt M
    Ann Hematol; 2012 Feb; 91(2):287-9. PubMed ID: 21494796
    [No Abstract]   [Full Text] [Related]  

  • 20. Stevens-Johnson syndrome and toxic epidermal necrolysis.
    Prendiville J
    Adv Dermatol; 2002; 18():151-73. PubMed ID: 12528405
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.